DTPw-HBV Kft (GSK)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameDTPw-HBV Kft (GSK)
Drug Alias NameZilbrixZilbrix PQ
ClassificationVaccines > Biological material > Toxoid vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsStreptococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNigeriaMali
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsStreptococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A